Cure My Disease

Don't miss your cure!

 Log in / Sign up

Brain aneurysm repair: Stent-Assisted coiling put to the test

NCT ID NCT07683377

Disease control Sponsor: Tang-Du Hospital Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 06, 2026 · Last updated Jul 07, 2026 · Updated 1 time

Summary

This trial investigates the safety and effectiveness of using a stent along with coil embolization to treat ruptured brain aneurysms. The procedure is performed within a week of the bleeding event in patients aged 18 to 80 with wide-neck aneurysms. Researchers are monitoring for stroke, disability, and how well the aneurysm is sealed, both immediately and up to a year later.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
stent-assisted coil embolization
What this could lead to
If successful, this approach could offer a safer, more effective way to treat ruptured brain aneurysms and reduce the risk of rebleeding.
What could go wrong
This is a single-center study with a moderate sample size, and results may not apply to all patients. There is a risk of stroke or other complications from the procedure.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 174 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jan 2026

Expected to finish

Aug 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 80 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patients aged 18-80 with a single ruptured cystic aneurysm at the center, or multiple aneurysms with a clear responsible lesion, only treat the responsible lesion * Aneurysms with a wide neck, neck ≥4mm, or neck/body ratio \>1/2 * Treatment performed within 7 days of the last hemorrhage * Patients undergoing interventional treatment using a stent, including cases of remedial stent use.5. Hunt \& Hess grade 1-3 Exclusion Criteria: * Exclude patients who meet the inclusion criteria but fail to undergo successful SAC embolization * Exclude non-cystic aneurysms, such as dissection, pseudoaneurysm, and distal aneurysm patients * Patients with other cerebrovascular diseases, including AVM, DAVF, Moyamoya disease, and arterial stenosis greater than 50% * Patients unable to use intravenous antiplatelet drugs * Patients with poor condition prior to aneurysm rupture, mRS ≥ 2 * Exclude pregnant patients * Exclude patients with other severe preoperative diseases, such as malignant tumors or cardiopulmonary and renal diseases * Patients with multiple aneurysms where the responsible lesion cannot be identified and treatment is done for all

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Efficacy and safety are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

acquired aneurysmal subarachnoid hemorrhage brain aneurysm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Efficacy and safety Ruptured aneurysm of intracranial artery Stent-assisted coiling

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Tangdu Hospital,Fourth Military Medical University,Xi'an,Shaanxi 710038

    RECRUITING

    Xi'an, Shaanxi, 710038, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.